Designing effective vaccines for colorectal cancer. (Q38260051)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25313570%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

review article

1 reference

title

Designing effective vaccines for colorectal cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25313570%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

1 reference

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25313570%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

author name string

Sandip P Patel

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25313570%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

Takuya Osada

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25313570%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

Michael A Morse

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25313570%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

publication date

1 January 2014

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25313570%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25313570%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

volume

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25313570%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

issue

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25313570%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

page(s)

913-926

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25313570%20AND%20SRC:MED&resulttype=core&format=json

Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer

21 February 2020

cites work

1 reference

Metastatic colorectal cancer cells from patients previously treated with chemotherapy are sensitive to T-cell killing mediated by CEA/CD3-bispecific T-cell-engaging BiTE antibody

21 January 2018

1 reference

Immune infiltration in human tumors: a prognostic factor that should not be ignored

21 January 2018

1 reference

Dual roles for immunity in gastrointestinal cancers

21 January 2018

1 reference

Immunotherapy for treating metastatic colorectal cancer.

21 January 2018

1 reference

Immunotherapy for metastatic colorectal cancer: present status and new options

21 January 2018

1 reference

Plasmacytoid dendritic cells promote immunosuppression in ovarian cancer via ICOS costimulation of Foxp3(+) T-regulatory cells

21 January 2018

1 reference

Human plasmacytoid dendritic cells efficiently cross-present exogenous Ags to CD8+ T cells despite lower Ag uptake than myeloid dendritic cell subsets.

21 January 2018

1 reference

Immunogenicity of targeted lentivectors.

21 January 2018

1 reference

Dendritic Cell-Induced Th1 and Th17 Cell Differentiation for Cancer Therapy

21 January 2018

1 reference

Depletion of plasmacytoid dendritic cells inhibits tumor growth and prevents bone metastasis of breast cancer cells

21 January 2018

1 reference

Cancer immunoediting: integrating immunity's roles in cancer suppression and promotion

21 January 2018

1 reference

Lymphocytic reaction to colorectal cancer is associated with longer survival, independent of lymph node count, microsatellite instability, and CpG island methylator phenotype

21 January 2018

1 reference

Effector memory T cells, early metastasis, and survival in colorectal cancer

21 January 2018

1 reference

Induced and natural regulatory T cells in human cancer

21 January 2018

1 reference

Prognostic role of FOXP3+ regulatory T cells infiltrating human carcinomas: the paradox of colorectal cancer

21 January 2018

1 reference

β-Catenin promotes colitis and colon cancer through imprinting of proinflammatory properties in T cells

21 January 2018

1 reference

Depletion of tumor-infiltrating macrophages is associated with amphoterin expression in colon cancer

21 January 2018

1 reference

Prognostic value of indoleamine 2,3-dioxygenase expression in colorectal cancer: effect on tumor-infiltrating T cells.

21 January 2018

1 reference

TGF-beta 1 attenuates the acquisition and expression of effector function by tumor antigen-specific human memory CD8 T cells

21 January 2018

1 reference

Prognostic significance of circulating IL-10 and IL-6 serum levels in colon cancer patients undergoing surgery

21 January 2018

1 reference

Adjuvant 5-fluorouracil and leucovorin with or without interferon alfa-2a in colon carcinoma: National Surgical Adjuvant Breast and Bowel Project protocol C-05.

21 January 2018

1 reference

Randomized trial of adjuvant therapy in colon carcinoma: 10-year results of NSABP protocol C-01.

21 January 2018

1 reference

Adjuvant active specific immunotherapy for stage II and III colon cancer with an autologous tumor cell vaccine: Eastern Cooperative Oncology Group Study E5283.

21 January 2018

1 reference

Active specific immunotherapy for stage II and stage III human colon cancer: a randomised trial

21 January 2018

1 reference

Efficiency of adjuvant active specific immunization with Newcastle disease virus modified tumor cells in colorectal cancer patients following resection of liver metastases: results of a prospective randomized trial

21 January 2018

1 reference

Clinical effects of adjuvant active specific immunotherapy differ between patients with microsatellite-stable and microsatellite-instable colon cancer

21 January 2018

1 reference

The cancer vaccine roller coaster

21 January 2018

1 reference

Phase I clinical trial of a recombinant canarypoxvirus (ALVAC) vaccine expressing human carcinoembryonic antigen and the B7.1 co-stimulatory molecule

21 January 2018

1 reference

Combination chemotherapy and ALVAC-CEA/B7.1 vaccine in patients with metastatic colorectal cancer

21 January 2018

1 reference

Diversified prime and boost protocols using recombinant vaccinia virus and recombinant non-replicating avian pox virus to enhance T-cell immunity and antitumor responses

21 January 2018

1 reference

An alphavirus vector overcomes the presence of neutralizing antibodies and elevated numbers of Tregs to induce immune responses in humans with advanced cancer

21 January 2018

1 reference

MUC1 vaccine for individuals with advanced adenoma of the colon: a cancer immunoprevention feasibility study

21 January 2018

1 reference

Phase I study utilizing a novel antigen-presenting cell-targeted vaccine with Toll-like receptor stimulation to induce immunity to self-antigens in cancer patients

21 January 2018

1 reference

Frequent high-level expression of the immunotherapeutic target Ep-CAM in colon, stomach, prostate and lung cancers.

21 January 2018

1 reference

Cross-trial analysis of immunologic and clinical data resulting from phase I and II trials of MVA-5T4 (TroVax) in colorectal, renal, and prostate cancer patients

21 January 2018

1 reference

Evaluation of MVA-5T4 as a novel immunotherapeutic vaccine in colorectal, renal and prostate cancer

21 January 2018

1 reference

Analysis of pre-treatment markers predictive of treatment benefit for the therapeutic cancer vaccine MVA-5T4 (TroVax).

21 January 2018

1 reference

Phase I clinical study of anti-apoptosis protein, survivin-derived peptide vaccine therapy for patients with advanced or recurrent colorectal cancer

21 January 2018

1 reference

The feasibility of Cep55/c10orf3 derived peptide vaccine therapy for colorectal carcinoma

21 January 2018

1 reference

Exploiting the mutanome for tumor vaccination.

21 January 2018

1 reference

Comparative Immunogenicity in Rhesus Monkeys of DNA Plasmid, Recombinant Vaccinia Virus, and Replication-Defective Adenovirus Vectors Expressing a Human Immunodeficiency Virus Type 1 gag Gene

21 January 2018

1 reference

Enhanced T-cell immunogenicity of plasmid DNA vaccines boosted by recombinant modified vaccinia virus Ankara in humans

21 January 2018

1 reference

Modulation of tumor immunity by therapeutic monoclonal antibodies

21 January 2018

1 reference

Phase III trial of 5-fluorouracil and leucovorin plus either 3H1 anti-idiotype monoclonal antibody or placebo in patients with advanced colorectal cancer

21 January 2018

1 reference

Complement decay accelerating factor (DAF)/CD55 in cancer.

21 January 2018

1 reference

Randomized double-blind phase II survival study comparing immunization with the anti-idiotypic monoclonal antibody 105AD7 against placebo in advanced colorectal cancer

21 January 2018

1 reference

Trastuzumab emtansine for HER2-positive advanced breast cancer

21 January 2018

1 reference

Immunopharmacologic response of patients with B-lineage acute lymphoblastic leukemia to continuous infusion of T cell-engaging CD19/CD3-bispecific BiTE antibody blinatumomab

21 January 2018

1 reference

PROVENGE (Sipuleucel-T) in prostate cancer: the first FDA-approved therapeutic cancer vaccine.

21 January 2018

1 reference

Sipuleucel-T immunotherapy for castration-resistant prostate cancer

21 January 2018

1 reference

Tumor cell lysate-pulsed dendritic cells induce a T cell response against colon cancer in vitro and in vivo

21 January 2018

1 reference

Clinical Benefit of Allogeneic Melanoma Cell Lysate-Pulsed Autologous Dendritic Cell Vaccine in MAGE-Positive Colorectal Cancer Patients.

21 January 2018

1 reference

A Randomized Trial ofEx vivoCD40L Activation of a Dendritic Cell Vaccine in Colorectal Cancer Patients: Tumor-Specific Immune Responses Are Associated with Improved Survival

21 January 2018

1 reference

A pilot study on the immunogenicity of dendritic cell vaccination during adjuvant oxaliplatin/capecitabine chemotherapy in colon cancer patients.

21 January 2018

1 reference

Vaccination of metastatic colorectal cancer patients with matured dendritic cells loaded with multiple major histocompatibility complex class I peptides

21 January 2018

1 reference

Altered peptide ligand vaccination with Flt3 ligand expanded dendritic cells for tumor immunotherapy

21 January 2018

1 reference

Generation of carcinoembryonic antigen (CEA)-specific T-cell responses in HLA-A*0201 and HLA-A*2402 late-stage colorectal cancer patients after vaccination with dendritic cells loaded with CEA peptides

21 January 2018

1 reference

A randomized phase II study of immunization with dendritic cells modified with poxvectors encoding CEA and MUC1 compared with the same poxvectors plus GM-CSF for resected metastatic colorectal cancer.

21 January 2018

1 reference

Improved Survival with Ipilimumab in Patients with Metastatic Melanoma

21 January 2018

1 reference

Clinical and immunologic responses to active specific cancer vaccines in human colorectal cancer

21 January 2018

1 reference

Chimeric antigen receptor-modified T cells in chronic lymphoid leukemia

21 January 2018

1 reference

Efficacy and toxicity management of 19-28z CAR T cell therapy in B cell acute lymphoblastic leukemia

21 January 2018

1 reference

Clinical Impact of Different Classes of Infiltrating T Cytotoxic and Helper Cells (Th1, Th2, Treg, Th17) in Patients with Colorectal Cancer

21 January 2018

1 reference

Tumor-Infiltrating FOXP3+ T Regulatory Cells Show Strong Prognostic Significance in Colorectal Cancer

21 January 2018

1 reference

Induction of Tumor-Specific Cytotoxic T Lymphocytes in Cancer Patients by Autologous Tumor RNA-Transfected Dendritic Cells

21 January 2018

1 reference

Preoperative Mobilization of Circulating Dendritic Cells by Flt3 Ligand Administration to Patients With Metastatic Colon Cancer

21 January 2018

1 reference

Natural Human Plasmacytoid Dendritic Cells Induce Antigen-Specific T-Cell Responses in Melanoma Patients

21 January 2018

1 reference

Vaccination of colorectal cancer patients with CEA-loaded dendritic cells: antigen-specific T cell responses in DTH skin tests

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.2217/IMT.14.61

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25313570%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

1 reference